Type 2 Diabetes in Childhood: Clinical Characteristics and Role of β-Cell Autoimmunity
- 567 Downloads
The global obesity epidemic has led to dramatic increases in the incidence and prevalence of type 2 diabetes mellitus (T2DM) among youth worldwide. In today’s clinical practice it has become increasingly difficult to distinguish type 1 diabetes mellitus (T1DM) from T2DM as many children with T1DM are overweight at diagnosis. Numerous recent publications note a significant proportion of physician-diagnosed T2DM youth with evidence of pancreatic autoimmunity, exemplifying the challenges in distinguishing between T1DM and T2DM. The clinical implications of the phenomenon of antibody positivity in phenotypic T2DM youth, also referred to as “type 1.5 diabetes” (T1.5 DM), “double diabetes,” “latent autoimmune diabetes in youth” (LADY), and “hybrid diabetes,” are unclear at present. Current and future work should determine if the presence of autoantibodies in phenotypic T2DM youth/children affects clinical course; this will facilitate the development of optimal treatment strategies.
KeywordsType 2 diabetes in youth Type 1.5 diabetes Diabetes autoantibodies Antibody-positive phenotypic T2DM youth Accelerator hypothesis β-cell autoimmunity
Conflicts of interest: A. Badaru: none; C. Pihoker: has received grant support from the Centers for Disease Control and Prevention/National Institute of Diabetes and Digestive and Kidney Diseases.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 5.Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care. 2000;23(3):381–9.Google Scholar
- 22.Knerr I, Wolf J, Reinehr T, Stachow R, Grabert M, Schober E, et al. The ‘accelerator hypothesis’: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia. 2005;48(12):2501–4.PubMedCrossRefGoogle Scholar
- 39.•• Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010;33(9):1970–5. This paper is important because the large sample size and ethnic/racial diversity of the TODAY study participants represents the largest and best-characterized sample of American youth with recent-onset T2DM and provides the most current data on the prevalence of autoimmunity in phenotypic T2DM youth in the United States.Google Scholar
- 40.Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997;350(9087):1288–93.PubMedCrossRefGoogle Scholar
- 44.• Tfayli H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009;58(3):738–44. In this study, insulin clamp studies were undertaken to delineate metabolic differences in insulin sensitivity and secretion in diabetes autoantibody (DAA)–positive and DAA-negative obese youth with clinically designated T2DM. DAA-positive participants were found to have severe β-cell failure and insulin deficiency, whereas DAA-negative youth had severe insulin resistance and relative insulin deficiency.Google Scholar
- 46.• Pozzilli P, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care. 2011;34(Suppl 2):S166–70.This recent review examines the epidemiologic evidence and pathophysiologic mechanisms relevant to the increasing incidence of T1DM and T2DM in youth. Diagnostic and classification challenges pertaining to antibody-positive youth with T2DM are discussed.Google Scholar
- 47.Donath MY, Storling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Berl). 2003;81(8):455–70.Google Scholar